FDA Approvals in Oncology: July-September 2023
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Category: Policy
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
A study that examined the catchment areas of 102 cancer centers in the U.S. found that while over a...
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
Throughout his career as a cancer researcher, Robert A. Winn, MD, has seen a familiar pattern in progress. Each...